IT1283225B1 - Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle - Google Patents

Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle

Info

Publication number
IT1283225B1
IT1283225B1 IT96MI000468A ITMI960468A IT1283225B1 IT 1283225 B1 IT1283225 B1 IT 1283225B1 IT 96MI000468 A IT96MI000468 A IT 96MI000468A IT MI960468 A ITMI960468 A IT MI960468A IT 1283225 B1 IT1283225 B1 IT 1283225B1
Authority
IT
Italy
Prior art keywords
strains
pharmaceutical composition
same
bacteria
therapy
Prior art date
Application number
IT96MI000468A
Other languages
English (en)
Inventor
Renata Maria Anna Ve Cavaliere
Simone Claudio De
Original Assignee
Renata Maria Anna Ve Cavaliere
Simone Claudio De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11373572&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1283225(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of ITMI960468A0 publication Critical patent/ITMI960468A0/it
Priority to IT96MI000468A priority Critical patent/IT1283225B1/it
Application filed by Renata Maria Anna Ve Cavaliere, Simone Claudio De filed Critical Renata Maria Anna Ve Cavaliere
Priority to PT97830040T priority patent/PT795604E/pt
Priority to ES97830040T priority patent/ES2200145T3/es
Priority to AT97830040T priority patent/ATE246509T1/de
Priority to DE69723898T priority patent/DE69723898T2/de
Priority to EP97830040A priority patent/EP0795604B1/en
Priority to DK97830040T priority patent/DK0795604T3/da
Priority to CA2198518A priority patent/CA2198518C/en
Priority to US08/813,776 priority patent/US6225104B1/en
Priority to JP05367397A priority patent/JP4057091B2/ja
Priority to CN97103444A priority patent/CN1110547C/zh
Priority to MX9701816A priority patent/MX9701816A/es
Priority to KR1019970007970A priority patent/KR100472061B1/ko
Publication of ITMI960468A1 publication Critical patent/ITMI960468A1/it
Publication of IT1283225B1 publication Critical patent/IT1283225B1/it
Application granted granted Critical
Priority to US09/796,432 priority patent/US20010012629A1/en
Priority to US10/174,779 priority patent/US7959911B2/en
Priority to US10/644,787 priority patent/US20040259227A1/en
Priority to US11/484,029 priority patent/USRE41276E1/en
Priority to US13/112,800 priority patent/US20110217759A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
IT96MI000468A 1996-03-11 1996-03-11 Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle IT1283225B1 (it)

Priority Applications (18)

Application Number Priority Date Filing Date Title
IT96MI000468A IT1283225B1 (it) 1996-03-11 1996-03-11 Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
DK97830040T DK0795604T3 (da) 1996-03-11 1997-02-05 Bakteriestammer med ændret galdesyremetabolisme og deres anvendelse
AT97830040T ATE246509T1 (de) 1996-03-11 1997-02-05 Bakterien-stämme mit verändertem gallensäuren- stoffwechsel und deren verwendung
ES97830040T ES2200145T3 (es) 1996-03-11 1997-02-05 Cepas de bacterias con metabolismo alterado de acidos biliares y su uso.
PT97830040T PT795604E (pt) 1996-03-11 1997-02-05 Estirpes de bacterias com metabolismo alterado de acidos biliares e sua utilizacao
DE69723898T DE69723898T2 (de) 1996-03-11 1997-02-05 Bakterien-Stämme mit verändertem Gallensäuren-Stoffwechsel und deren Verwendung
EP97830040A EP0795604B1 (en) 1996-03-11 1997-02-05 Strains of bacteria with altered metabolism of bile acids and their use
CA2198518A CA2198518C (en) 1996-03-11 1997-02-26 Strains of bacteria and pharmaceutical composition containing such strains and use of same for preventing and treating diseases associated with or caused by alterated metabolism of bile acid
US08/813,776 US6225104B1 (en) 1996-03-11 1997-03-07 Strains of bacteria and pharmaceutical composition containing one or more of such strains and use of same for preventing and treating diseases associated with or caused by altered metabolism of bile acids
JP05367397A JP4057091B2 (ja) 1996-03-11 1997-03-07 細菌株、及び該細菌株を含む薬学的組成物、並びに胆汁酸に関しての変化した代謝に関連するか、引き起こされる疾患を治療するための、上記組成物の使用
CN97103444A CN1110547C (zh) 1996-03-11 1997-03-10 细菌菌株和包含它们的药物组合物以及该菌株在预防和治疗疾病上的用途
KR1019970007970A KR100472061B1 (ko) 1996-03-11 1997-03-10 박테리아 균주와 이와 같은 균주를 함유하는 의약조성물 및 변형된 담즙산 대사에 의해 야기되거나 관련된 질병의 예방 및 치료용으로서의 그의 용도
MX9701816A MX9701816A (es) 1996-03-11 1997-03-10 Cepas de bacterias y composicion farmaceutica que contiene dichas cepas y uso de la misma para prevenir y tratar enfermedades asociadas con el metabolismo alterado de acidos biliares o causadas por el mismo.
US09/796,432 US20010012629A1 (en) 1996-03-11 2001-03-02 Strains of bacteria and pharmaceutical composition containing one or more of such strains and use of same for preventing and treating diseases associated with or caused by altered metabolism of bile acids
US10/174,779 US7959911B2 (en) 1996-03-11 2002-06-18 Strains of bacteria and pharmaceutical composition containing one or more of such strains and use of same for preventing and treating diseases associated with or caused by altered metabolism of bile acids
US10/644,787 US20040259227A1 (en) 1996-03-11 2003-08-21 Strains of bacteria and pharmaceutical composition containing one or more of such strains and use of same for preventing and treating diseases asociated with or caused by altered metabolism of bile acids
US11/484,029 USRE41276E1 (en) 1996-03-11 2006-07-11 Strains of bacteria and pharmaceutical composition containing one or more of such strains and use of same for preventing and treating diseases associated with or caused by altered metabolism of bile acids
US13/112,800 US20110217759A1 (en) 1996-03-11 2011-05-20 Strains of bacteria and pharmaceutical composition containing one or more of such strains and use of same for preventing and treating diseases associated with or caused by altered metabolism of bile acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI000468A IT1283225B1 (it) 1996-03-11 1996-03-11 Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle

Publications (3)

Publication Number Publication Date
ITMI960468A0 ITMI960468A0 (it) 1996-03-11
ITMI960468A1 ITMI960468A1 (it) 1997-09-11
IT1283225B1 true IT1283225B1 (it) 1998-04-16

Family

ID=11373572

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96MI000468A IT1283225B1 (it) 1996-03-11 1996-03-11 Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle

Country Status (13)

Country Link
US (6) US6225104B1 (it)
EP (1) EP0795604B1 (it)
JP (1) JP4057091B2 (it)
KR (1) KR100472061B1 (it)
CN (1) CN1110547C (it)
AT (1) ATE246509T1 (it)
CA (1) CA2198518C (it)
DE (1) DE69723898T2 (it)
DK (1) DK0795604T3 (it)
ES (1) ES2200145T3 (it)
IT (1) IT1283225B1 (it)
MX (1) MX9701816A (it)
PT (1) PT795604E (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
IT1309427B1 (it) * 1999-05-28 2002-01-23 Mendes S U R L Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
ITRM20010763A1 (it) * 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.
US7374606B2 (en) * 2003-06-27 2008-05-20 Canon Kabushiki Kaisha Water-based ink and ink recording method
WO2005089093A2 (en) * 2003-11-21 2005-09-29 Dow Global Technologies Inc. Improved expression systems with sec-system secretion
CN1663573B (zh) * 2004-03-04 2010-04-28 青岛东海药业有限公司 一种稳定安全的微生态制剂及其制备方法和用途
US20070224285A1 (en) * 2004-03-31 2007-09-27 Calpis Co., Ltd Agent for Preventing or Suppressing Hepatopathy and Functional Food for Preventing or Suppressing Hepatopathy
CN101641441A (zh) * 2007-01-31 2010-02-03 陶氏环球技术公司 用于提高表达的细菌前导序列
WO2009110816A1 (ru) * 2008-03-04 2009-09-11 Dikovskiy Aleksander Vladimiro Фармацевтическая композиция на основе гепатопротектора и пребиотика, получение и применение
KR20200106088A (ko) * 2012-01-16 2020-09-10 엘라자베스 맥켄나 간 질환들 및 장애들의 치료를 위한 조성물들 및 방법들
WO2014047588A1 (en) 2012-09-21 2014-03-27 Elizabeth Mckenna Naturally occurring cpg oligonucleotide compositions and therapeutic applications thereof
EP3172973B1 (en) * 2015-11-27 2020-04-08 DAFLORN Ltd. Probiotic formula, process of its preparation and use
SG11201804255QA (en) * 2015-12-14 2018-06-28 Metabogen Ab Treatment of intrahepatic cholestasis and related liver diseases
CN115569141B (zh) * 2022-10-17 2023-10-20 中国农业科学院兰州兽医研究所 脱氧胆酸在制备抗口腔链球菌产品中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1221734B (it) * 1983-02-24 1990-07-12 Schiena Michele Giuseppe Di Ursodesossicolico solfato acido sale sodico
US5079240A (en) * 1990-03-15 1992-01-07 The Regents Of The University Of California Synthetic conjugated bile acid and method of use thereof
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
IT1255241B (it) * 1992-07-22 1995-10-20 Simos Contos Derivato di acido biliare e suo uso in terapia
JP2992945B2 (ja) * 1994-03-11 1999-12-20 カルピス株式会社 ラクトバチルス・アシドフィルス乳酸菌
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
DE69600525T2 (de) * 1996-12-23 1998-12-10 Sitia Yomo Spa Lyophilisierte, lebende Bakerien enthaltende Nahrungszusammensetzung
IT1309427B1 (it) * 1999-05-28 2002-01-23 Mendes S U R L Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso
ITRM20010763A1 (it) * 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.
TWI241912B (en) * 2002-10-30 2005-10-21 Food Industry Res & Dev Inst Novel Acid-and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol

Also Published As

Publication number Publication date
DK0795604T3 (da) 2003-10-27
ATE246509T1 (de) 2003-08-15
US20040259227A1 (en) 2004-12-23
ITMI960468A1 (it) 1997-09-11
CN1165857A (zh) 1997-11-26
KR100472061B1 (ko) 2005-07-08
MX9701816A (es) 1998-04-30
US20110217759A1 (en) 2011-09-08
KR970065708A (ko) 1997-10-13
US7959911B2 (en) 2011-06-14
EP0795604A3 (en) 1998-04-15
US6225104B1 (en) 2001-05-01
JP4057091B2 (ja) 2008-03-05
CA2198518C (en) 2010-04-13
ITMI960468A0 (it) 1996-03-11
US20010012629A1 (en) 2001-08-09
US20030082791A1 (en) 2003-05-01
DE69723898T2 (de) 2004-01-29
DE69723898D1 (de) 2003-09-11
EP0795604B1 (en) 2003-08-06
JPH1086A (ja) 1998-01-06
USRE41276E1 (en) 2010-04-27
PT795604E (pt) 2003-12-31
CA2198518A1 (en) 1997-09-11
EP0795604A2 (en) 1997-09-17
ES2200145T3 (es) 2004-03-01
CN1110547C (zh) 2003-06-04

Similar Documents

Publication Publication Date Title
US5091171B2 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
IT1283225B1 (it) Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
CA2289717A1 (en) Novel therapy for constipation
NO954440L (no) 2 pyridylmetylenpolyazamakrocyklo-fosfonsyrer, komplekser og derivater derav, for anvendelse som kontrastmidler
ATE124405T1 (de) 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel.
CA2172513A1 (en) Aminocyclohexylesters and uses thereof
EP0773022A3 (de) Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden, enthaltend Sympthomimeticum und Pantothenol und/oder Pantothensäure
WO1997004788A3 (en) Use of calendula glycosides for the treatment of psoriasis
IT1222395B (it) Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare
FI945510A0 (fi) Klavulaanihapon diamiinisuolat
AU7125991A (en) Novel antiulcer substance
AU7493594A (en) 10-substituted 1,8-dihydroxy-9(10H) anthracenone pharmpharmaceuticals
PL306158A1 (en) Phenyl-substituted 1,4-dihydropyridines, method of obtaining them and therapeutic agents containing such compounds
DE69009765D1 (de) Kynurensäurederivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES2191671T3 (es) Esteres de 1,4-dihidropiridina 4-fenil-3-sustituidos.
EP0457151A3 (en) Herbicidal composition and method for killing weeds using the same
ITMI952754A1 (it) Ceppi di batteri composizione farmaceutica contenente uno o piu' di tali ceppi ed uso dei medesimi per la prevenzione e la terapia della malattie associate o provocate da un alterato metabolismo degli acidi biliari
IT8882546A0 (it) Impianto per il trattamento superficiale e l'eventuale accumulo dei prodotti, in particolare diprodotti in legno come serramenti, infissi e simili.

Legal Events

Date Code Title Description
0001 Granted